Cencora Inc., US03073E1055

Cencora stock carries an 18.2 percent analyst upside

Published on 10/06/2026 at 17:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora stock traded at USD 313.72 on October 6, 2026, while its 52-week high stood at USD 377.54. Fiscal fourth quarter results are scheduled for November 4, 2026.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks
Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora (ISIN US03073E1055) stock was trading at USD 313.72 on the NYSE on October 6, 2026, at 11:45 a.m. ET, down 0.38 percent from the previous session close of USD 314.93. The next scheduled company checkpoint is the fiscal fourth quarter 2026 results release on November 4, 2026.

Analysts see USD 370.85

According to MarketBeat, 16 analysts carry a Moderate Buy consensus for Cencora, with 13 Buy ratings and three Holds. Their average 12-month price target is USD 370.85, while the published high and low targets are USD 440.00 and USD 285.00.

Using the October 6 NYSE price, the average target lies 18.2 percent above the stock. The range matters: the low target is below the market price, while the high target is 40.3 percent above it, leaving a wide spread in analyst expectations.

Quarterly growth sets the benchmark

MarketBeat reported that Cencora delivered adjusted earnings per share of USD 4.48 in its latest reported quarter, versus a USD 4.35 consensus estimate. Revenue reached USD 84.75 billion, up 5.1 percent from the same quarter a year earlier.

The earnings comparison gives the valuation debate a concrete base. Cencora combines a quarterly earnings beat with revenue growth, but the share price remains USD 63.82 below its 52-week high of USD 377.54, a 16.9 percent gap calculated from the October 6 quote.

November results set the next test

According to Business Wire, Cencora announced on October 2, 2026, that it will publish fiscal fourth quarter 2026 results before trading begins on November 4, 2026, followed by a conference call at 8:30 a.m. ET. That date puts the next report ahead of the market, making guidance and adjusted earnings the main figures for the analyst target range.

Stock trades below yearly high

Cencora stock was last at USD 313.72 on the NYSE on October 6, 2026, at 11:45 a.m. ET. The company had a market capitalization of USD 61.0 billion at that time.

Cencora stock facts

  • Company: Cencora, Inc.
  • ISIN: US03073E1055
  • Ticker: COR
  • Trading venue: NYSE
  • Price: USD 313.72 on October 6, 2026, at 11:45 a.m. ET
  • Market capitalization: USD 61.0 billion as of October 6, 2026
  • 52-week range: USD 244.82-USD 377.54 as of October 6, 2026
  • Sector / Industry: Health Care / Health Care Distributors

Upcoming dates for Cencora stock

  • November 4, 2026: Fiscal fourth quarter 2026 results before the NYSE open

More news and analyses on Cencora stock

Disclaimer...

en | US03073E1055 | CENCORA INC. | boerse | 70244016 | bgmi